The U.S. Food and Drug Administration is set to give Pfizer-BioNTech authorization for its COVID-19 vaccine to be used on people between the ages of 12 and 15. A government official told CNN that Pfizer applied for emergency use authorization and the “process should be straightforward.”
The FDA is currently reviewing data submitted to support the extended use.
A clinical trial involving more than 2,000 12-to-15-year-olds revealed that the vaccine was well tolerated. It had an efficacy rate of 100% within the age group.
Although children are less likely to die from COVID-19, it is still possible for them to spread the virus. Pfizer and BioNTech also began testing the vaccine on children between the ages of 6 months and 11 years old.
Currently, the Pfizer-BioNTech vaccine is used in people 16 years old and older. The Moderna vaccine is not cleared for people under 18.
No COVID-19 vaccine has been authorized for children to use.